PCSK9 antibodies meta-analysis in media Posted on April 28, 2015May 27, 2015 by siriomedicine Posted in Interviews, Media, SIRIO MEDICINE More Preliminary Signs That The New Cholesterol Drugs May Improve Outcomes New drugs show promise for treating high cholesterol PCSK9 Inhibitors Appear to Lower Death Risk: PCSK9 inhibitors appeared to reduce overall- and CVD-mortality in a pooled analysis of clinical trials New Drug Class Slashes ‘Bad’ Cholesterol: Review. If approved, medications could be used by people who don’t respond to statins PCSK9 Antibodies: Another Option for Treating Adult Hypercholesterolemia Study: New Cholesterol drugs show promise PCSK9 Antibodies in Adults With Hypercholesterolemia PCSK9-Hemmung mit Abnahme der Mortalität assoziiert PCSK9-Inhibitoren: Beste Lipidsenker, die es je gab? New Drug Class Shows Promise In Lowering Bad Cholesterol Meta-analysis hints at survival benefit with PCSK9 inhibitors Statin Alternative Cuts Cholesterol Without Muscle Pain Meta-analysis: PCSK9 inhibitors reduce mortality, MI Review Touts Benefits of New Cholesterol Drugs, but Editorial Calls for Cautious Enthusiasm Meta-analysis of PCSK9 inhibition in treatment of dyslipidaemia shows mortality benefit Systematic review suggests mortality benefits of new cholesterol lowering biologics PCSK9 antibodies: another option for treating adult hypercholesterolemia Can PCSK9 Inhibitors Improve Hypercholesterolemia Outcomes? PCSK9 Inhibitors Cut LDL Cholesterol, CVD Risk 荟萃分析：PCSK9抑制剂或降低死亡率和心梗发生率 New Study Strengthens the Case that LDL Causes Heart Disease Mortaliteitsvoordeel met PCSK9-remming in behandeling dyslipidaemia blijkt uit meta-analyse Nieuwe cholesterolremmers effectief maar duur Nuevo medicamento para el colesterol Jab cuts cholesterol better than statins and may halve patients’ chances of suffering a heart attack and dying Nuovi farmaci per abbassare il colesterolo PCSK9 Inhibitors Cut LDL Cholesterol, CVD Risk Nieuwe cholesterolremmers effectief maar duur 生物制剂降血脂有利于降低死亡率 Biologics cut cholesterol, may reduce mortality Οι αναστολείς PCSK9 μειώνουν τη θνησιμότητα και το ΟΕΜ 脂質異常のPCSK9抗体、死亡減 Nuovi farmaci contro l’ipercolesterolemia Biologics cut cholesterol, may reduce mortality Biologics cut cholesterol, may reduce mortality Biologics cut cholesterol, may reduce mortality PCSK9 Inhibitors Safe, Effective in Hypercholesterolemia PCSK9 Antibody Therapy Offers Promising Alternative to Statins, Study Suggests Share this: Click to email a link to a friend (Opens in new window) Email Click to share on X (Opens in new window) X Click to print (Opens in new window) Print Click to share on Facebook (Opens in new window) Facebook Like Loading... Related
SIRIO MEDICINE 